Industry Intellectual Property Enforcers Named To New Posts 08/12/2009 by Catherine Saez and William New, Intellectual Property Watch Leave a Comment The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) today announced the appointment of a new director of intellectual property and trade, effective 7 December. Meanwhile, in the United States, new coordinator for IP enforcement has been cleared.
Microsoft Drafts Consumers In Fight Against Software Piracy: Carrot And Stick 06/12/2009 by Monika Ermert for Intellectual Property Watch 1 Comment US software giant Microsoft said Thursday that users globally have started to join the fight against software piracy by sending in over 150,000 reports about problems with fake Microsoft products over the last two years.
Bilski Decision Likely To Narrow Patentable Subject Matter In US, Panel Says 24/11/2009 by Steven Seidenberg for Intellectual Property Watch Leave a Comment For years, the United States has taken an expansive position on the types of inventions that are patentable. Software, medical tests, and business methods – for example – have all been granted patents. But that is likely to change when the US Supreme Court hands down its decision in Bilski v. Kappos, according to most members of a 19 November panel, Patentable Subject Matter After the Bilski Oral Argument, hosted by American University Law School and the Federal Circuit Bar Association.
Challenge To GlennBeckRapedAndMurderedAYoungGirlIn1990.com Loses WIPO Dispute 10/11/2009 by William New, Intellectual Property Watch 5 Comments Conservative US radio talk show host Glenn Beck, known for bad-mouthing others on radio and opposition television station Fox News, has lost a case at the World Intellectual Property Organization trying to force the takedown of website parodying him, www.GlennBeckRapedAndMurderedAYoungGirlIn1990.com.
US Groups Duel Over Access To ACTA Negotiation 09/11/2009 by Robinson Esalimba for Intellectual Property Watch and William New 7 Comments During the most recent negotiations on the Anti-Counterfeiting Trade Agreement (ACTA) in Seoul, Korea on 4-6 November, about which no information is available, US industry and public interest groups issued statements taking widely divergent positions on progress of the talks.
ICANN Gives Green Light To .中国, .рф, .إمارات , But No Timeline For New Top-Level Domains 01/11/2009 by Monika Ermert for Intellectual Property Watch 6 Comments The board of directors of the Internet Corporation for Assigned Names and Numbers (ICANN) this week opened up the root zone for non-Latin country-code top level domains (internationalised or IDN ccTLDs). Starting 16 November, ICANN will accept applications for ccTLDs in Chinese, Cyrillic, Japanese, Korean or Arabic characters. In addition to the Chinese ccTLD .cn there will be .中国, in addition to the Russian .ru there will be .рф, and in addition to the United Arab Emirates’ .ae, .إمارات will be possible. ICANN leadership qualified the step as historic, but also said it was only a first step.
Bilski Impact On Biotech Seen As Minimal; Experts See Court Shift 29/10/2009 by Sharon McLoone for Intellectual Property Watch Leave a Comment The intellectual property community is anxiously awaiting the United States Supreme Court’s reaction next month in the closely watched Bilski v. Kappos case, a legal feud over the validity of a patent covering a method of commodities trading. The outcome of the case could have broad implications for the patentability of business methods and software, which could potentially wallop the technology industry. It likely will have less impact in the biotechnology arena, experts said at the Biotechnology Industry Organization’s Intellectual Property Counsels Committee conference in Washington on Tuesday.
Changing Winds For Gene Patenting In the US? Stakeholders React To Draft Report 29/10/2009 by Catherine Saez, Intellectual Property Watch 1 Comment A United States health department advisory group this month produced a new draft report on gene patenting and licensing with recommendations suggesting that excessive patenting can limit patients’ access to gene testing and might not foster genetic research. The recommendations were supported by a variety of health professionals but put the biotechnology industry on edge.
US Federal Circuit May Offer Patent, Tech Policy Guidance For High Court 23/10/2009 by Winter Casey for Intellectual Property Watch 1 Comment WASHINGTON, DC – The United States Federal Circuit Court of Appeals should act more like a teacher to the Supreme Court and do a better job explaining its policy reasoning when it makes decisions on innovation-related cases, a top patent law academic said late Tuesday. If the Federal Circuit was clearer in how it landed at certain conclusions in patent disputes it might result in the Supreme Court opting to get involved in fewer patent cases, said Rochelle Dreyfuss, a professor at New York University School of Law.
Kappos’ Early Days At USPTO: Many Changes, Few Funds 23/10/2009 by Dugie Standeford for Intellectual Property Watch 1 Comment Reform of the United States patent system, better patent quality and greater international cooperation among patent offices are just a few of the jobs new United States Patent and Trademark Office chief David Kappos has on his plate.